MedTrace Logo

Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain

NCT00020605 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2018-12-13

No results posted yet for this study

Summary

RATIONALE: Naloxone may be effective in treating constipation that may be caused by opioid pain medications such as morphine.

PURPOSE: Phase III trial to determine the effectiveness of naloxone in relieving constiption in patients who are receiving opioids for chronic pain.

Conditions

  • Constipation, Impaction, and Bowel Obstruction
  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

naloxone hydrochloride

Sponsors & Collaborators

Principal Investigators

  • Nathaniel Katz, MD · Dana-Farber Cancer Institute

Study Design

Purpose
SUPPORTIVE_CARE

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00020605 on ClinicalTrials.gov